Compare IMRX & PAYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMRX | PAYS |
|---|---|---|
| Founded | 2008 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 340.7M | 375.7M |
| IPO Year | 2021 | 2020 |
| Metric | IMRX | PAYS |
|---|---|---|
| Price | $5.74 | $7.27 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $17.20 | $9.42 |
| AVG Volume (30 Days) | ★ 1.3M | 801.0K |
| Earning Date | 05-04-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 37.75 | ★ 85.71 |
| EPS | N/A | ★ 0.09 |
| Revenue | N/A | ★ $24,120,434.00 |
| Revenue This Year | N/A | $33.83 |
| Revenue Next Year | N/A | $14.89 |
| P/E Ratio | ★ N/A | $80.39 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.67 | $3.08 |
| 52 Week High | $10.08 | $8.88 |
| Indicator | IMRX | PAYS |
|---|---|---|
| Relative Strength Index (RSI) | 59.88 | 67.53 |
| Support Level | $5.11 | $5.05 |
| Resistance Level | $7.67 | N/A |
| Average True Range (ATR) | 0.45 | 0.47 |
| MACD | 0.05 | 0.08 |
| Stochastic Oscillator | 44.47 | 96.85 |
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.